Abstract
Purpose. The outcomes of pharmacist-managed diabetes care services in a community health center were studied. Methods. Eligible patients were over age 18 years and had a diagnosis of type 2 diabetes mellitus. Patients were randomly assigned by the clinical pharmacist and nurse to the intervention group (n = 76) or control group (n = 73). Patients in the intervention group were enrolled in a pharmacist-managed diabetes care program. Patients in the control group received the standard diabetes care. The primary endpoint was reduction in glycosylated hemoglobin (HbA1c); secondary outcome measures included weight loss, an improved body mass index, decreased blood pressure, and an improved lipid panel. Quality-of-life measures (health level, satisfaction, impact, worry about disease, and worry about social and vocational issues) were also assessed. Results. Demographic differences between groups were not remarkable. Mean HbA1c levels fell significantly (p <0.05) from baseline to nine months in both groups. A difference of 1.0 was reported between the groups' HbA1c levels (95% confidence interval, 0.08-1.78; p <0.05). Satisfaction level improved from 63.7 to 77.4 in the intervention group, which was significant when compared with the control group, whose satisfaction score improved from 57.0 to 63.4 (p <0.05). Conclusion. Patients with type 2 diabetes mellitus who received pharmacist-managed diabetes care demonstrated improved HbA1c, systolic blood pressure, and low-density-lipoprotein cholesterol levels and quality-of-life measures and met treatment goals more often than patients receiving standard care.
| Original language | English |
|---|---|
| Pages (from-to) | 2116-2122 |
| Number of pages | 7 |
| Journal | American Journal of Health-System Pharmacy |
| Volume | 63 |
| Issue number | 21 |
| DOIs | |
| State | Published - Nov 1 2006 |
Fingerprint
All Science Journal Classification (ASJC) codes
- Pharmaceutical Science
- Leadership and Management
Cite this
Outcomes of pharmacist-managed diabetes care services in a community health center. / Scott, David M.; Boyd, Steven T.; Stephan, Michelle; Augustine, Samuel C.; Reardon, Thomas P.
In: American Journal of Health-System Pharmacy, Vol. 63, No. 21, 01.11.2006, p. 2116-2122.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Outcomes of pharmacist-managed diabetes care services in a community health center
AU - Scott, David M.
AU - Boyd, Steven T.
AU - Stephan, Michelle
AU - Augustine, Samuel C.
AU - Reardon, Thomas P.
PY - 2006/11/1
Y1 - 2006/11/1
N2 - Purpose. The outcomes of pharmacist-managed diabetes care services in a community health center were studied. Methods. Eligible patients were over age 18 years and had a diagnosis of type 2 diabetes mellitus. Patients were randomly assigned by the clinical pharmacist and nurse to the intervention group (n = 76) or control group (n = 73). Patients in the intervention group were enrolled in a pharmacist-managed diabetes care program. Patients in the control group received the standard diabetes care. The primary endpoint was reduction in glycosylated hemoglobin (HbA1c); secondary outcome measures included weight loss, an improved body mass index, decreased blood pressure, and an improved lipid panel. Quality-of-life measures (health level, satisfaction, impact, worry about disease, and worry about social and vocational issues) were also assessed. Results. Demographic differences between groups were not remarkable. Mean HbA1c levels fell significantly (p <0.05) from baseline to nine months in both groups. A difference of 1.0 was reported between the groups' HbA1c levels (95% confidence interval, 0.08-1.78; p <0.05). Satisfaction level improved from 63.7 to 77.4 in the intervention group, which was significant when compared with the control group, whose satisfaction score improved from 57.0 to 63.4 (p <0.05). Conclusion. Patients with type 2 diabetes mellitus who received pharmacist-managed diabetes care demonstrated improved HbA1c, systolic blood pressure, and low-density-lipoprotein cholesterol levels and quality-of-life measures and met treatment goals more often than patients receiving standard care.
AB - Purpose. The outcomes of pharmacist-managed diabetes care services in a community health center were studied. Methods. Eligible patients were over age 18 years and had a diagnosis of type 2 diabetes mellitus. Patients were randomly assigned by the clinical pharmacist and nurse to the intervention group (n = 76) or control group (n = 73). Patients in the intervention group were enrolled in a pharmacist-managed diabetes care program. Patients in the control group received the standard diabetes care. The primary endpoint was reduction in glycosylated hemoglobin (HbA1c); secondary outcome measures included weight loss, an improved body mass index, decreased blood pressure, and an improved lipid panel. Quality-of-life measures (health level, satisfaction, impact, worry about disease, and worry about social and vocational issues) were also assessed. Results. Demographic differences between groups were not remarkable. Mean HbA1c levels fell significantly (p <0.05) from baseline to nine months in both groups. A difference of 1.0 was reported between the groups' HbA1c levels (95% confidence interval, 0.08-1.78; p <0.05). Satisfaction level improved from 63.7 to 77.4 in the intervention group, which was significant when compared with the control group, whose satisfaction score improved from 57.0 to 63.4 (p <0.05). Conclusion. Patients with type 2 diabetes mellitus who received pharmacist-managed diabetes care demonstrated improved HbA1c, systolic blood pressure, and low-density-lipoprotein cholesterol levels and quality-of-life measures and met treatment goals more often than patients receiving standard care.
UR - http://www.scopus.com/inward/record.url?scp=33751040268&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33751040268&partnerID=8YFLogxK
U2 - 10.2146/ajhp060040
DO - 10.2146/ajhp060040
M3 - Article
C2 - 17057049
AN - SCOPUS:33751040268
VL - 63
SP - 2116
EP - 2122
JO - American Journal of Health-System Pharmacy
JF - American Journal of Health-System Pharmacy
SN - 1079-2082
IS - 21
ER -